Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Upper GI Series: Barium Swallow01:24

Upper GI Series: Barium Swallow

The Barium Swallow Study, or a Barium Esophagogram, is a diagnostic imaging method used to visualize the upper gastrointestinal (GI) tract, including the esophagus, stomach, and small intestine. It employs barium sulfate, a radiopaque contrast material, to provide clear images of the upper digestive system, helping to identify abnormalities, diseases, or structural issues.
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Intraoperative Tumor-to-Background Ratios Across Different Subsites of the Oral Cavity Using an Integrin-Specific Fluorescent Tracer.

Cancers·2026
Same author

Longitudinal assessment and predictors of subjective taste change after hematopoietic cell transplantation (HCT).

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Decisional Conflict in Palliative Head and Neck Cancer Patients.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Getting the right measure: Gait speed assessment and outcomes in older patients with cancer.

Journal of geriatric oncology·2026
Same author

Photobiomodulation Therapy in the Management of Orofacial Neuropathic Pain-WALT Position Paper 2026.

Journal of clinical medicine·2026
Same author

Individualized Prognostic Counseling for Decision-Making in Head and Neck Cancer: A Nonrandomized Clinical Trial.

JAMA otolaryngology-- head & neck surgery·2026

Related Experiment Video

Updated: May 26, 2026

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
08:32

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models

Published on: March 1, 2015

Swallowing dysfunction in cancer patients.

, Judith E Raber-Durlacher, Mike T Brennan

    Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
    |December 30, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Dysphagia, or swallowing dysfunction, is a serious complication for cancer patients, impacting their quality of life. This review highlights assessment tools, prevalence, and the effects of various cancer treatments on swallowing.

    Related Experiment Videos

    Last Updated: May 26, 2026

    Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
    08:32

    Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models

    Published on: March 1, 2015

    Area of Science:

    • Oncology
    • Gastroenterology
    • Clinical Medicine

    Background:

    • Dysphagia is a significant and often underreported complication in cancer patients.
    • It can be debilitating, leading to depression and posing life-threatening risks.

    Purpose of the Study:

    • To review literature on dysphagia in cancer patients from 1990-2010.
    • To focus on assessment tools, prevalence, complications, and quality of life impacts.
    • To specifically examine dysphagia in head and neck cancer patients treated with chemoradiation.

    Main Methods:

    • Comprehensive literature search of MEDLINE/PubMed and EMBASE.
    • Inclusion of English-language papers reporting dysphagia as a side effect of cancer and its therapy.
    • Identification of relevant articles through primary search and reference lists.

    Main Results:

    • A diverse array of dysphagia assessment tools were identified.
    • Dysphagia is linked to tumor impact, surgery, chemotherapy, radiotherapy, and targeted therapies like EGFR inhibitors.
    • Oral complications such as xerostomia can worsen subjective dysphagia; it affects various cancers, not just head and neck.

    Conclusions:

    • Swallowing impairment is a relevant acute and long-term complication across many cancer types.
    • Further prospective studies are needed to understand the trajectory of dysphagia and its quality of life impact.
    • Research should encompass diverse treatment modalities, including novel targeted therapies.